HighVista Strategies LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$392,000
-65.2%
315,880
-45.3%
0.25%
-72.2%
Q4 2021$1,125,000
-6.3%
577,031
+31.7%
0.90%
+12.7%
Q3 2021$1,201,000
+23.7%
438,239
+42.2%
0.80%
+15.4%
Q2 2021$971,000308,0960.69%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders